Calumet Specialty Products Partners reported record quarterly earnings of $4.65 per share driven by a tight specialty market, though management cautions this windfall is unsustainable amid concerns ov
Calumet Inc. reported second-quarter revenues exceeding analyst expectations by 29%, prompting analysts to raise 2026 revenue forecasts and reduce loss estimates. Consequently, the consensus price tar
Calumet Specialty Products Partners reported $175 million Adjusted EBITDA for Q2 2026 and updated MaxSAF sustainable aviation fuel expansion targets to 200 million gallons by 2028.
Calumet Specialty Products Partners stock surged over 10% following a Q2 revenue beat of $1.45 billion, aided by debt reduction and the Montana Renewables MaxSAF project. Goldman Sachs raised its pric
Calumet Inc. reported Q2 2026 revenue of $1.45 billion, driven by specialty and renewable fuel sales including the MaxSAF®150 restart. The company posted a narrower net loss of $95.9 million despite p
Calumet Inc reported a Q2 net loss of $95.9 million with EPS of $(1.09), missing analyst estimates despite exceeding revenue expectations. Adjusted EBITDA reached $175.2 million, offsetting some conce
Calumet Specialty Products Partners reported Q2 2026 sales of $1.445 billion, up 40.8% year-over-year, driven by its Specialty Products segment. Adjusted EBITDA rose to $159.3 million despite a net lo
Calumet, Inc. reported Q2 revenue of $1.45 billion, significantly exceeding FactSet's estimate of $1.12 billion. The company indicated stronger than anticipated sales performance for the second quarte
Calumet Specialty Products Partners reported Q2 2026 revenue of $1.45 billion, a 40.77% year-over-year increase. The company exceeded earnings estimates with an EPS of $0.68, surpassing expectations b
Calumet Specialty Products Partners announced its Q2 2026 financial results, outlining key operational metrics and performance outlook for stakeholders.
Calumet Specialty Products Partners reported Q2 CY2026 revenue of $1.45 billion, up 40.8% year-on-year, significantly beating Wall Street expectations. The specialty refiner posted adjusted EBITDA of
ChemBrief